Posts

Showing posts from February, 2023

Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders

Image
Conscious Medicine | Integrative & Functional Medicine Atlanta 6601 Sugarloaf Pkwy Ste 220, Duluth, GA 30097, United States +16782617879 https://consciousmed.co/ https://consciousmed.co/i-medicine/ https://consciousmed.co/6-key-signs-of-liver-detox-working-what-to-look-for/ https://consciousmed.co/sibo-die-off-symptoms-what-you-need-to-know/ https://consciousmed.co/how-to-treat-sibo-naturally/ Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders Searching for your content... Browse News Releases In-Language News Contact Us 888-776-0942 from 8 AM - 10 PM ET Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders News provided by Jan 25, 2023, 08:35 ET Share this article Share this article - Animal model studies highlight potential of the c-Abl inhibitor IkT-148009 to

Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders | MarketScreener

Image
Conscious Medicine | Integrative & Functional Medicine Atlanta 6601 Sugarloaf Pkwy Ste 220, Duluth, GA 30097, United States +16782617879 https://consciousmed.co/ https://consciousmed.co/i-medicine/ https://consciousmed.co/6-key-signs-of-liver-detox-working-what-to-look-for/ https://consciousmed.co/sibo-die-off-symptoms-what-you-need-to-know/ https://consciousmed.co/how-to-treat-sibo-naturally/ Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders | MarketScreener - Animal model studies highlight potential of the c-Abl inhibitor IkT-148009 to modify the course of Parkinson's Disease and Suppress Protein Pathology - BOSTON and ATLANTA, Jan. 25, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Pa

Author Correction: Patterns of somatic structural variation in human cancer genomes | NatureClose bannerClose banner

Image
Conscious Medicine | Integrative & Functional Medicine Atlanta 6601 Sugarloaf Pkwy Ste 220, Duluth, GA 30097, United States +16782617879 https://consciousmed.co/ https://consciousmed.co/i-medicine/ https://consciousmed.co/6-key-signs-of-liver-detox-working-what-to-look-for/ https://consciousmed.co/sibo-die-off-symptoms-what-you-need-to-know/ https://consciousmed.co/how-to-treat-sibo-naturally/ Author Correction: Patterns of somatic structural variation in human cancer genomes | NatureClose bannerClose banner Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. Advertisement Author Correction: Patterns of somatic structural variation in human cancer genomes